Selected research
Industry Growth & Trends
Global Isosorbide Mononitrate Sustained-release Tablet Industry Growth and Trends Forecast to 2032
Market perspective
The global Isosorbide Mononitrate Sustained-release Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Isosorbide Mononitrate Sustained-release Tablet include Lotus Pharmaceuticals, Mayo Clinic, Recipeharm, Hefei Cosource Pharmacetical, Keyuan Pharmaceutical, Lepu Pharmaceuticals and Lukang Jituan Saite Yaoye, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Isosorbide Mononitrate Sustained-release Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Isosorbide Mononitrate Sustained-release Tablet market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Isosorbide Mononitrate Sustained-release Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Isosorbide Mononitrate Sustained-release Tablet.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Isosorbide Mononitrate Sustained-release Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Isosorbide Mononitrate Sustained-release Tablet Market by Company
Lotus Pharmaceuticals
Mayo Clinic
Recipeharm
Hefei Cosource Pharmacetical
Keyuan Pharmaceutical
Lepu Pharmaceuticals
Lukang Jituan Saite Yaoye
Isosorbide Mononitrate Sustained-release Tablet Segment by Type
40mg
50mg
Other
Isosorbide Mononitrate Sustained-release Tablet Segment by Application
Hospital
Clinic
Other
Isosorbide Mononitrate Sustained-release Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isosorbide Mononitrate Sustained-release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isosorbide Mononitrate Sustained-release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isosorbide Mononitrate Sustained-release Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isosorbide Mononitrate Sustained-release Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Isosorbide Mononitrate Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg
- 50mg
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Lotus Pharmaceuticals
- Mayo Clinic
- Recipeharm
- Hefei Cosource Pharmacetical
- Keyuan Pharmaceutical
- Lepu Pharmaceuticals
- Lukang Jituan Saite Yaoye
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Estimates and Forecasts (2021-2032)
- 1.3 Isosorbide Mononitrate Sustained-release Tablet Market by Type
- 1.3.1 40mg
- 1.3.2 50mg
- 1.3.3 Other
- 1.4 Global Isosorbide Mononitrate Sustained-release Tablet Market Size by Type
- 1.4.1 Global Isosorbide Mononitrate Sustained-release Tablet Market Size Overview by Type (2021-2032)
- 1.4.2 Global Isosorbide Mononitrate Sustained-release Tablet Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Isosorbide Mononitrate Sustained-release Tablet Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Isosorbide Mononitrate Sustained-release Tablet Industry Trends
- 2.2 Isosorbide Mononitrate Sustained-release Tablet Industry Drivers
- 2.3 Isosorbide Mononitrate Sustained-release Tablet Industry Opportunities and Challenges
- 2.4 Isosorbide Mononitrate Sustained-release Tablet Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Isosorbide Mononitrate Sustained-release Tablet Revenue (2021-2026)
- 3.2 Global Top Players by Isosorbide Mononitrate Sustained-release Tablet Sales (2021-2026)
- 3.3 Global Top Players by Isosorbide Mononitrate Sustained-release Tablet Price (2021-2026)
- 3.4 Global Isosorbide Mononitrate Sustained-release Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Isosorbide Mononitrate Sustained-release Tablet Major Company Production Sites & Headquarters
- 3.6 Global Isosorbide Mononitrate Sustained-release Tablet Company, Product Type & Application
- 3.7 Global Isosorbide Mononitrate Sustained-release Tablet Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Isosorbide Mononitrate Sustained-release Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Isosorbide Mononitrate Sustained-release Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Isosorbide Mononitrate Sustained-release Tablet Tier 1, Tier 2, and Tier 3
4 Isosorbide Mononitrate Sustained-release Tablet Regional Status and Outlook
- 4.1 Global Isosorbide Mononitrate Sustained-release Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Isosorbide Mononitrate Sustained-release Tablet Historic Market Size by Region
- 4.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales in Volume by Region (2021-2026)
- 4.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales in Value by Region (2021-2026)
- 4.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Isosorbide Mononitrate Sustained-release Tablet Forecasted Market Size by Region
- 4.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales in Volume by Region (2027-2032)
- 4.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales in Value by Region (2027-2032)
- 4.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Isosorbide Mononitrate Sustained-release Tablet by Application
- 5.1 Isosorbide Mononitrate Sustained-release Tablet Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Isosorbide Mononitrate Sustained-release Tablet Market Size by Application
- 5.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Market Size Overview by Application (2021-2032)
- 5.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Lotus Pharmaceuticals
- 6.1.1 Lotus Pharmaceuticals Company Information
- 6.1.2 Lotus Pharmaceuticals Business Overview
- 6.1.3 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.1.5 Lotus Pharmaceuticals Recent Developments
- 6.2 Mayo Clinic
- 6.2.1 Mayo Clinic Company Information
- 6.2.2 Mayo Clinic Business Overview
- 6.2.3 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.2.5 Mayo Clinic Recent Developments
- 6.3 Recipeharm
- 6.3.1 Recipeharm Company Information
- 6.3.2 Recipeharm Business Overview
- 6.3.3 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.3.5 Recipeharm Recent Developments
- 6.4 Hefei Cosource Pharmacetical
- 6.4.1 Hefei Cosource Pharmacetical Company Information
- 6.4.2 Hefei Cosource Pharmacetical Business Overview
- 6.4.3 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.4.5 Hefei Cosource Pharmacetical Recent Developments
- 6.5 Keyuan Pharmaceutical
- 6.5.1 Keyuan Pharmaceutical Company Information
- 6.5.2 Keyuan Pharmaceutical Business Overview
- 6.5.3 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.5.5 Keyuan Pharmaceutical Recent Developments
- 6.6 Lepu Pharmaceuticals
- 6.6.1 Lepu Pharmaceuticals Company Information
- 6.6.2 Lepu Pharmaceuticals Business Overview
- 6.6.3 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.6.5 Lepu Pharmaceuticals Recent Developments
- 6.7 Lukang Jituan Saite Yaoye
- 6.7.1 Lukang Jituan Saite Yaoye Company Information
- 6.7.2 Lukang Jituan Saite Yaoye Business Overview
- 6.7.3 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 6.7.5 Lukang Jituan Saite Yaoye Recent Developments
7 North America by Country
- 7.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales by Country
- 7.1.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026)
- 7.1.3 North America Isosorbide Mononitrate Sustained-release Tablet Sales Forecast by Country (2027-2032)
- 7.2 North America Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 7.2.1 North America Isosorbide Mononitrate Sustained-release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Isosorbide Mononitrate Sustained-release Tablet Market Size by Country (2021-2026)
- 7.2.3 North America Isosorbide Mononitrate Sustained-release Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales by Country
- 8.1.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026)
- 8.1.3 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Forecast by Country (2027-2032)
- 8.2 Europe Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 8.2.1 Europe Isosorbide Mononitrate Sustained-release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Isosorbide Mononitrate Sustained-release Tablet Market Size by Country (2021-2026)
- 8.2.3 Europe Isosorbide Mononitrate Sustained-release Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales by Country
- 9.1.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 9.2.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Isosorbide Mononitrate Sustained-release Tablet Sales by Country
- 10.1.1 South America Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026)
- 10.1.3 South America Isosorbide Mononitrate Sustained-release Tablet Sales Forecast by Country (2027-2032)
- 10.2 South America Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 10.2.1 South America Isosorbide Mononitrate Sustained-release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Isosorbide Mononitrate Sustained-release Tablet Market Size by Country (2021-2026)
- 10.2.3 South America Isosorbide Mononitrate Sustained-release Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales by Country
- 11.1.1 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 11.2.1 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Isosorbide Mononitrate Sustained-release Tablet Value Chain Analysis
- 12.1.1 Isosorbide Mononitrate Sustained-release Tablet Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Isosorbide Mononitrate Sustained-release Tablet Production Mode & Process
- 12.2 Isosorbide Mononitrate Sustained-release Tablet Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Isosorbide Mononitrate Sustained-release Tablet Distributors
- 12.2.3 Isosorbide Mononitrate Sustained-release Tablet Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst